Chelsea Therapeutics shares double after panel recommends drug

(Reuters) – Chelsea Therapeutics International Ltd’s shares more than doubled in value on Wednesday after an independent panel to the U.S. health regulator recommended an approval for the company’s…

    

Leave a Reply

Your email address will not be published.